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Neil D Jelly1*, Issam I Hussain1, Jennifer Eremin2, Oleg Eremin2,3 and Mohamed El-Sheemy1,2Retraction
This article has been retracted [1] by the authors be-
cause errors were noted in the methodology employed
in the experiments which invalidate the results reported.
The authors apologise for any inconvenience caused.
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